Profile: Prometheus Laboratories Inc. is a specialty pharmaceutical company. Our product zyloprim® is used for patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Our trandate tablets are adrenergic receptor blocking agents that have both selective alpha1-adrenergic and nonselective beta-adrenergic receptor blocking actions in a single substance. These tablets are indicated in the management of hypertension. These tablets may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics. Ridaura® is indicated in the management of adults with active classical or definite rheumatoid arthritis who have had an insufficient therapeutic response or an adequate trial of full doses of one or more nonsteroidal anti-inflammatory drugs. This product should be added to a comprehensive baseline program, including non-drug therapies.

FDA Registration Number: 3003586938